NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) | PA 25 304

Frequently Asked Questions (FAQs)

What is the NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)?

It is a discretionary grant program administered by the National Institutes of Health (NIH) that supports early-stage, high-potential research projects. The R21 mechanism is intended for research that is still exploratory or developmental, where the work is aimed at testing new concepts, generating initial evidence, or creating a foundation for later, more definitive studies.

What is the Funding Opportunity Number for this announcement?

The Funding Opportunity Number is PA 25 304.

What does "Parent R21" mean in this context?

"Parent" indicates a broad NIH-wide funding opportunity that multiple NIH institutes and centers may use to support projects aligned with their missions. This structure allows a wide range of topics, as long as they fit within the mission priorities of the relevant NIH institute or center.

What is the main purpose of this R21 opportunity?

The main purpose is to support research at early and conceptual stages, especially ideas that are innovative and potentially high-impact but not yet supported by a fully mature evidence base. The award is designed to help investigators test feasibility, develop early prototypes, or conduct proof-of-concept work that can lead to larger studies later.

What kinds of projects are a good fit for an R21 award?

Projects that fit the exploratory/developmental intent of the R21 mechanism may include proof-of-concept experiments, pilot studies, feasibility testing, early prototype development, or preliminary validation of a new approach. The emphasis is on innovation and potential impact rather than extensive preliminary results.

What types of research activities does NIH highlight as appropriate for this opportunity?

The opportunity highlights research aimed at developing novel techniques, agents, methodologies, models, or applications that could meaningfully influence biomedical, behavioral, or clinical research fields, as long as the project remains in early/conceptual stages.

Are clinical trials allowed under this specific R21 announcement?

No. The announcement title explicitly states "Clinical Trial Not Allowed." Applicants must ensure that the proposed work does not meet NIH's definition of a clinical trial under this particular parent announcement.

If my project involves humans, does that automatically make it a clinical trial?

The only clear instruction provided here is that clinical trials are not allowed and applicants must ensure their work does not meet NIH's definition of a clinical trial. The description does not provide additional criteria for determining whether a study meets that definition.

What is the funding instrument type for this opportunity?

The funding instrument type is a Grant.

What makes this R21 mechanism different from more typical research proposals?

NIH explicitly positions the R21 to support work that may be higher risk than typical research proposals, with the potential for major advances such as breakthrough findings or the creation of new tools that shift how a research area operates.

Who is eligible to apply?

A wide range of organizations are eligible, including state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations (other than federally recognized tribal governments); public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (when applying under those nonprofit categories and not as institutions of higher education); for-profit organizations other than small businesses; and small businesses.

Are minority-serving institutions and other community-rooted organizations eligible?

Yes. The opportunity specifically lists eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); and faith-based or community-based organizations.

Can federal agencies apply?

Yes. The opportunity includes eligible federal agencies among the listed eligible applicants.

Can organizations outside the United States apply?

Yes. The opportunity includes non-U.S. entities (foreign organizations) as eligible applicants.

Are U.S. territories or possessions included as eligible applicants?

Yes. U.S. territories or possessions are listed among eligible applicants.

Are tribal governments that are not federally recognized eligible to apply?

Yes. The opportunity lists tribal governments that are not federally recognized among the eligible applicants.

Does this opportunity specify an award ceiling?

No. The provided information states that the listing does not specify an award ceiling, which is described as common for parent NIH announcements where funding depends on institute priorities, available funds, application volume, and scientific merit.

Does the opportunity specify the expected number of awards?

No. The provided information indicates that the expected number of awards is not specified in the listing.

What factors influence whether an application is funded under a parent NIH announcement?

Based on the provided information, funding levels and outcomes may depend on institute priorities, availability of funds, application volume, and scientific merit.

What is the original closing date listed for this opportunity?

The opportunity record shows an original closing date of 2028-01-07.

When was this opportunity record created?

The creation date listed is 2024-12-18.

Which public service areas is this opportunity associated with?

The listing places the opportunity under broad public service areas including education, environment, health, income security, and social services.

Which CFDA/Assistance Listing numbers are associated with this opportunity?

The opportunity is associated with multiple Assistance Listing numbers, including 93.113, 93.121, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.361, 93.837, 93.838, 93.839, 93.840, 93.855, 93.865, 93.866, 93.867, and 93.879.

What does it mean that many Assistance Listing numbers are included?

The provided information indicates that the multiple Assistance Listing numbers reflect that many NIH institutes and centers may use this parent R21 announcement to support mission-relevant exploratory projects.

What is this grant generally intended to help applicants produce?

It is intended to help applicants generate initial results, methods, or enabling resources that can unlock a new line of investigation or support a future, more comprehensive NIH application.

Is this opportunity best suited for large, mature research programs?

The provided description positions this as an entry point for bold, early research ideas that are not ready for a large-scale project, but are strong enough in rationale and approach to justify targeted support.